Inovyn launches bio-attributed epichlorohydrin
Ineos subsidiary Inovyn has become the world’s first commercial producer of bio-attributed epichlorohydrin from renewable feedstock. Branded Reodrin, this is made at a site in Tavaux, France. Applications are expected in sectors including composites for wind turbines, wastewater treatment and lightweight coatings for electric vehicles.
The new material uses a second-generation, renewable feedstock that eliminates the use of energy crops and palm materials, thus using 99% less land and water than conventional feedstocks. It is also RSB-certified as enabling a greenhouse gas saving of almost 70% compared to fossil- and palm-based epichlorohydrin.
RELATED ARTICLES
UK-based speciality chemicals company Elementis has announced that, by mutual agreement, CEO Paul Waterman will step down no later than the AGM in April 2025, remaining available as required for any transition or other support until the end of July. A successor is now being sought.
Swiss CDMO Siegfried has inaugurated its new global R&D centre for drug substances at its site in Evionnaz.
International Chemical Investors Group (ICIG), the owner of WeylChem and many other European chemical assets, has acquired the European Advanced Organics business of Valtris Specialty Chemicals.
SOCMA, the trade association of the US speciality chemical manufacturing industry, has published an open letter to the pending Trump administration, urging it to “prioritise policies that encourage advancement, streamline regulatory processes and incentivise domestic manufacturing”.
BASF has formed a partnership with Slovenian white biotech Acies Bio. Under this it will further develop the latter’s OneCarbonBio fermentation platform to derive methanol for the production of fatty alcohols for home and personal care ingredients, notably surfactants.
Peptides CDMO AmbioPharm, has broken ground on a 650 m2, $28 million expansion project at its Shanghai manufacturing site. This is due to be complete in 2H 2025 and will produce over 8 tonnes/year of crude peptide.
